Potential for future therapies to enhance healthy aging lies in drugs that release minute quantities of hydrogen sulfide (H2S).
New research suggests that future therapies for healthy aging may harness the potential of drugs releasing small amounts of hydrogen sulfide (H2S) gas, specifically targeting cells. // A study from the University of Exeter, funded by the US Army and charity The United Mitochondrial Disease Foundation, found that targeting tiny amounts of H2S to specific areas of cells in adult worms using an H2S-releasing molecule called AP39, greatly improved health and activity as they aged (1✔ ✔Trusted Source
Mitochondrial sulfide promotes lifespan and healthspan through distinct mechanisms in developing versus adult-treated Caenorhabditis elegans
Go to source).
‘Promising new research indicates that drugs releasing trace amounts of hydrogen sulfide (H2S) could pave the way for future therapies to support healthy aging by precisely targeting cells.
# Healthy Aging, #Drugs, #Future Therapy
’
The research, published in PNAS, concludes that targeting H2S specifically to the energy-generating machinery of cells (mitochondria) could one day be used as a healthy aging therapeutic. The research team administered AP39 to some worms from birth, and to others after reaching adulthood. They found that this compound improved the integrity of mitochondria – the “powerhouse” of cells, which produces our cells’ energy, and kept the worms’ muscles active and moving, even well into old age, and when given mid-way through their life course.
Revolutionizing Aging Therapies
A number of age-related conditions are linked to loss of mitochondrial function, including natural aging, neurodegenerative diseases such as Parkinson’s and Alzheimer’s as well as muscular dystrophy and primary mitochondrial diseases.The team also found a group of proteins that regulated how genes are expressed in aging (transcription factors).
Their transcription factors were found to be specifically targeted by H2S. This insight may identify new targets for therapy in aging and age-related conditions, particularly conditions affecting muscle.
Advertisement
Diseases related to aging take a huge toll on society. Our results indicate that H2S, administered to specific parts of the cell in tiny quantities, could one day be used to help people live healthier for longer.
Advertisement
The University of Exeter has assigned the underlying technology to its spin-out MitoRx Therapeutics, which has developed next-generation compounds with much better drug characteristics as potential medicines to combat diseases of aging including neurodegenerative disorders such as Huntington’s disease as well as rare childhood conditions such as muscular dystrophy.
Targeted Cellular Rejuvenation
Co-author Professor Matt Whiteman, from the University of Exeter, said: “This study is not about extending life – it’s about living healthier lives well into older age. This could have huge benefits to society. We’re excited to see this research move to the next stages over the coming years, and hope it will one day form the basis of new treatments which we have the potential to develop with MitoRx.”“We saw a small extension of lifespan in the worms that were targeted with H2S, and what’s unique here is that we extended healthspan – or the time they lived healthy lives. The worms still died, albeit later than normally expected, but they died very active and with young physiology.”
The paper is entitled ‘Mitochondrial sulfide promotes lifespan and healthspan through distinct mechanisms in developing versus adult treated Caenorhabditis elegans, and is published in PNAS.
Reference:
- Mitochondrial sulfide promotes lifespan and healthspan through distinct mechanisms in developing versus adult-treated Caenorhabditis elegans - (https://www.pnas.org/doi/10.1073/pnas.2216141120#:~:text=We%20show%20that%20small%2C%20clinically%20meaningful%20doses%20of,dysfunction%20are%20already%20manifested%2C%20also%20promoted%20healthy%20aging.)
Source-Eurekalert